XM does not provide services to residents of the United States of America.

Wall St Week Ahead-US small caps struggle as elevated interest rates take a toll



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Wall St Week Ahead-US small caps struggle as elevated interest rates take a toll</title></head><body>

By David Randall

NEW YORK, May 3 (Reuters) -The prospect of interest rates remaining elevated as the Federal Reserve battles inflation is further clouding the outlook for shares of smaller U.S. companies, which have lagged broader markets this year.

Small cap stocks surged at the end of 2023, as expectations grew that the Fed was done raising interest rates and would soon begin easing monetary policy. That would be a welcome change for smaller companies, which rely more heavily on debt financing and consumer spending.

But stubbornly strong inflation has eroded prospects of rate cuts this year, and small cap stocks have suffered as a result. The Russell 2000 is up just 0.4% year-to-date, far less than the S&P 500's 7.5% gain. Earnings are also expected to be shaky, giving investors little reason to shift allocations from larger companies and other, less risky parts of their portfolios.

"Investors are skeptical right now about small cap stocks because of higher rates and stickier inflation, and they need greater clarity that the Fed will be cutting rates this year before moving in," said Michael Arone, Chief Investment Strategist for State Street’s SPDR Business, who has been buying small caps in anticipation of rate cuts later in the year.

The case for smaller stocks may have improved over the last few days. U.S. employment data on Friday showed that jobs growth, while still relatively robust, slowed last month, easing fears that rates will remain elevated for the rest of the year. The Russell 2000 was up about 1% on the day.

On Wednesday, Fed Chairman Jerome Powell said he still believed rates were heading lower this year, despite stubborn inflation.

Futures markets on Friday showed investors pricing in around 45 basis points of interest rate cuts this year, from less than 30 priced in earlier this week. That remained far lower than the 150 points they had priced in January.

Stronger-than-expected earnings in coming weeks could help allay investor concerns. Overall, the Russell 2000 is expected to post earning growth of -8.4% over the most recent quarter, compared with a 10.2% earnings growth rate for the S&P 500, according to LSEG data. At the same, the Russell 2000 is trading at a forward price to earnings ratio of 22 compared with a 20 times earnings multiple for the S&P 500, making small-caps more expensive.

"The earnings pickup we expected has just not been there," said David Lefkowitz, CIO Head of US Equities at UBS Global Wealth Management, who has been overweight small caps since December. "I still think the preference for small makes sense, but it depends on your rate view."

Among the notable small cap companies reporting in the week ahead are nutrition company Bellring Brands BRBR.N, gambling company Light & Wonder LNW.O and oil and natural gas company Permian Resources PR.N.

Larger caps reporting next week include Walt Disney DIS.N, Wynn Resorts WYNN.O and Akamai Technologies AKAM.O, as US corporate earnings season continues.

Despite the encouraging developments of the last few days, few believe the path to rate cuts is clear.

Jill Carey Hall, equity & quant strategist at Bofa Global Research, said investors buying small caps should focus on companies positioned to withstand an extended Fed pause, including those with higher percentages of fixed dent and comparatively low leverage.

"It's too soon to price in more rate cuts," said Timothy Chubb, chief investment officer at Girard. "One number doesn't make a trend. Overall, the Fed is getting the evidence it needs.”


Russell 2000 vs S&P 500 performance year to date https://tmsnrt.rs/3Qw9uTE


Reporting by David Randall; Editing by Ira Iosebashvili and David Gregorio

Wall St Week Ahead runs every Friday. For the daily stock market report, please click .N
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.